Literature DB >> 2184885

Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion.

R K Harrison1, R L Stein.   

Abstract

Cyclophilin, the cytosolic binding protein for the immunosuppressive drug cyclosporin A, has recently been shown to be identical with peptidyl prolyl cis-trans isomerase [Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F.X. (1989) Nature 337, 476; Takahashi, N., Hayano, T., & Suzuki, M. (1989) Nature 337, 473]. To provide a mechanistic framework for studies of the interaction of cyclophilin with cyclosporin, we investigated the mechanism of the PPI-catalyzed cis to trans isomerization of Suc-Ala-Xaa-cis-Pro-Phe-pNA (Xaa = Ala, Gly). Our mechanistic studies of peptidyl prolyl cis-trans isomerase include the determination of steady-state kinetic parameters, pH and temperature dependencies, and solvent and secondary deuterium isotope effects. The results of these experiments support a mechanism involving catalysis by distortion in which the enzyme uses free energy released from favorable, noncovalent interactions with the substrate to stabilize a transition state that is characterized by partial rotation about the C-N amide bond.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184885     DOI: 10.1021/bi00459a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  Folding of barstar C40A/C82A/P27A and catalysis of the peptidyl-prolyl cis/trans isomerization by human cytosolic cyclophilin (Cyp18).

Authors:  R Golbik; G Fischer; A R Fersht
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

2.  Structural characterization of N-protonated amides: regioselective N-activation of medium-bridged twisted lactams.

Authors:  Michal Szostak; Lei Yao; Victor W Day; Douglas R Powell; Jeffrey Aubé
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

3.  Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements.

Authors:  Graham M West; Chandra L Tucker; Tao Xu; Sung Kyu Park; Xuemei Han; John R Yates; Michael C Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

4.  Catalytic mechanism of cyclophilin as observed in molecular dynamics simulations: pathway prediction and reconciliation of X-ray crystallographic and NMR solution data.

Authors:  Daniel Trzesniak; Wilfred F van Gunsteren
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

5.  Solvent Effects on the Energetics of Prolyl Peptide Bond Isomerization.

Authors:  Eric S Eberhardt; Stewart N Loh; Andrew P Hinck; Ronald T Raines
Journal:  J Am Chem Soc       Date:  1992       Impact factor: 15.419

6.  Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A.

Authors:  J Liu; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  A novel plant peptidyl-prolyl-cis-trans-isomerase (PPIase): cDNA cloning, structural analysis, enzymatic activity and expression.

Authors:  O Blecher; N Erel; I Callebaut; K Aviezer; A Breiman
Journal:  Plant Mol Biol       Date:  1996-11       Impact factor: 4.076

8.  Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.

Authors:  K D O'Neal; M V Chari; C H Mcdonald; R G Cook; L Y Yu-Lee; J D Morrisett; W T Shearer
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  A nonessential role for Arg 55 in cyclophilin18 for catalysis of proline isomerization during protein folding.

Authors:  Satish Babu Moparthi; Per Hammarström; Uno Carlsson
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  An analysis of the expression of cyclophilin C reveals tissue restriction and an intriguing pattern in the mouse kidney.

Authors:  J Friedman; I Weissman; J Friedman; S Alpert
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.